ENTRY       D07523                      Drug
NAME        Betaine (JAN);
            Cystadane (TN)
PRODUCT     CYSTADANE (Recordati Rare Diseases)
  GENERIC   BETAINE (Cosette Pharmaceuticals)
            BETAINE ANHYDROUS (Eton Pharmaceuticals)
            BETAINE ANHYDROUS FOR ORAL SOLUTION (Lukare Medical)
            BETAINE ANHYDROUS FOR ORAL SOLUTION (OAKRUM PHARMA)
FORMULA     C5H11NO2
EXACT_MASS  117.079
MOL_WEIGHT  117.1463
REMARK      Same as: C00719
            Therapeutic category: 3999
            ATC code: A16AA06
            Chemical structure group: DG00145
            Product (DG00145): D07523<JP/US>
EFFICACY    Antihomocystinuria
  DISEASE   Homocystinuria [DS:H00183]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
               A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
                A16AA Amino acids and derivatives
                 A16AA06 Betaine
                  D07523  Betaine (JAN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment
              Betaine
               D07523  Betaine (JAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              39  Other agents affecting metabolism
               399  Miscellaneous
                3999  Others
                 D07523  Betaine (JAN)
            Risk category of Japanese OTC drugs [BR:br08312]
             Third-class OTC drugs
              Inorganic and organic chemicals
               Betaine
                D07523  Betaine (JAN)
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D07523
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D07523
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D07523
DBLINKS     CAS: 107-43-7
            PubChem: 51091846
            ChEBI: 17750
            PDB-CCD: BET
            LigandBox: D07523
            NIKKAJI: J5.058J
ATOM        8
            1   N1d N    22.9600  -17.9200 #+
            2   C1b C    24.1500  -18.6200
            3   C1a C    21.7700  -18.6200
            4   C1a C    22.9600  -16.5200
            5   C6a C    25.4100  -17.9200
            6   O6a O    25.4100  -16.5200
            7   O6a O    26.6000  -18.6200 #-
            8   C1a C    22.9600  -19.3200
BOND        7
            1     1   2 1
            2     1   3 1
            3     1   4 1
            4     2   5 1
            5     5   6 2
            6     5   7 1
            7     1   8 1
///
